SetPoint System, newly approved by the FDA, can ease rheumatoid arthritis symptoms by delivering a small jolt of electricity to the vagus nerve.

The FDA just approved the SetPoint System, which electrically stimulates the vagus nerve to control inflammation from the ...

The FDA has approved the SetPoint System, an implantable device that stimulates the vagus nerve to treat moderate-to-severe ...

The implantable neurostimulation device activates the body's innate anti-inflammatory and immune-restorative pathways ...

The small implant helps relieve pain and joint swelling in rheumatoid arthritis and is being investigated for other ...

The FDA has approved the SetPoint System, a neuroimmune modulation device, for the treatment of adults with moderately to ...

The SetPoint System is an implanted device that stimulates the vagus nerve once a day. It was tested through a clinical trial at Northwell Health.

Motion control aspects that will be discussed include: 1) setpoint generator that creates smooth motion profiles through trajectory planning and input shaping; 2) multi-degree of freedom (DOF) ...

US FDA approves SetPoint Medical’s novel neuroimmune modulation device, SetPoint System for rheumatoid arthritis: Valencia, California Saturday, August 2, 2025, 17:00 Hrs [IST] ...

The Food and Drug Administration has approved a vagus nerve bioimplant to treat rheumatoid arthritis (RA). The scientific ...

SetPoint Medical's vagus nerve stimulator has received FDA approval for treating moderate-to-severe rheumatoid arthritis (RA) ...

The agency’s decision was based on the outcomes of the double-blind, randomised, sham-controlled RESET-RA study.